Across TCGA pan-cancer cohorts, FAT4 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated FAT4 data layer compared with 12 for mutation status and 1 for mass-spec protein.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher FAT4 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated FAT4 expression acts as an unfavorable survival marker, although some lineages such as KIRC and HNSC show a favorable association.
KIRC, HNSC, and MESO are the cancer types where FAT4 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.